Prostatype Genomics AB Financial Overview
Prostatype Genomics AB's market cap is currently kr12.95M. The company's EPS TTM is kr; its P/E ratio is -0.15; Prostatype Genomics AB is scheduled to report earnings on November 7, 2025, and the estimated EPS forecast is kr―. See an overview of income statement, balance sheet, and cash flow financials.